Biologic-based drugs have increasingly
Biologic-based drugs have increasingly dominated the pharmaceutical market
A staggering 39 million people worldwide could succumb to antibiotic-resistant
Pharma 4.0 is a transformative approach in drug manufacturing, promising to revolutionize
As we approach the fourth quarter of 2024, the global bio/pharma sector
Cell and gene therapies represent an emerging frontier in bio/pharmaceutical
The World Health Organization (WHO) has declared the recent
In the ever-evolving world of global supply chains, certain companies
Contract Development and Manufacturing Organizations (CDMOs)
The US Food and Drug Administration (FDA) has announced